Literature DB >> 19490957

Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.

Avni Y Joshi1, Vivek N Iyer, Jennifer L St Sauver, Robert M Jacobson, Thomas G Boyce.   

Abstract

The effectiveness of influenza vaccine over multiple influenza seasons in children less than 5 years of age has not been well studied. This is especially important to assess because of the recent recommendation for routine influenza vaccination in childhood. We conducted a matched case-control study to assess the vaccine effectiveness of Trivalent Inactivated Influenza Vaccine (TIV) against laboratory-confirmed, medically attended influenza among children 6-59 months of age at the start of each influenza season from 1999-2000 through 2006-2007 in Olmsted County, MN, USA. The children vaccinated against influenza accordingly to the 2007 ACIP guidelines had a lower risk of laboratory-confirmed medically attended influenza illness (Odds Ratio: 0.14, 95% Confidence Interval: 0.03-0.71) than the unvaccinated children. TIV provided strong protection against laboratory-confirmed medically attended influenza in children 6-59 months old in the fully vaccinated group. This trend continued in the partially vaccinated group (Odds Ratio: 0.27, 95% Confidence Interval: 0.07-0.97) but the protection provided maybe suboptimal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490957     DOI: 10.1016/j.vaccine.2009.05.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants.

Authors:  Carl T D'Angio; Roy J Heyne; Shahnaz Duara; Lucy C Holmes; T Michael O'Shea; Hongyue Wang; Dongwen Wang; Pablo J Sánchez; Robert C Welliver; Rita M Ryan; Kenneth C Schnabel; Caroline B Hall
Journal:  Pediatr Infect Dis J       Date:  2011-07       Impact factor: 2.129

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  Statement on Seasonal Influenza Vaccine for 2012-2013: Appendix I: New Evidence Review for Children 24 to 59 Months of Age: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors: 
Journal:  Can Commun Dis Rep       Date:  2012-08-01

4.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

5.  Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses.

Authors:  Mark G Thompson; Jessie Clippard; Joshua G Petrie; Michael L Jackson; Huong Q McLean; Manjusha Gaglani; Evelyn C Reis; Brendan Flannery; Arnold S Monto; Lisa Jackson; Edward A Belongia; Kempapura Murthy; Richard K Zimmerman; Swathi Thaker; Alicia M Fry
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

Review 6.  Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Authors:  Vytautas Usonis; Ioana Anca; Francis André; Roman Chlibek; Inga Ivaskeviciene; Atanas Mangarov; Zsófia Mészner; Roman Prymula; Pavol Simurka; Eda Tamm; Goran Tesović
Journal:  BMC Infect Dis       Date:  2010-06-14       Impact factor: 3.090

7.  Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly.

Authors:  Hang Xie; Xianghong Jing; Xing Li; Zhengshi Lin; Ewan Plant; Olga Zoueva; Hong Yang; Zhiping Ye
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

8.  Seasonal influenza vaccine effectiveness among children aged 6 to 59 months in southern China.

Authors:  Zhicong Yang; Zhiqiang Dong; Chuanxi Fu
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

9.  Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.

Authors:  Yin Wang; Tao Zhang; Liling Chen; Carolyn Greene; Yunfang Ding; Yuejia Cheng; Chao Yang; Shanshan Zeng; Jun Hua; Suizan Zhou; Ying Song; Lin Luan; Jun Zhang; Genming Zhao
Journal:  Vaccine       Date:  2016-03-24       Impact factor: 3.641

Review 10.  Effectiveness of seasonal influenza vaccines in children -- a systematic review and meta-analysis.

Authors:  Ivana Lukšić; Sarah Clay; Rachel Falconer; Drazen Pulanic; Igor Rudan; Harry Campbell; Harish Nair
Journal:  Croat Med J       Date:  2013-04       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.